You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

accelerated phase chronic myelogenous leukemia

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

Recruiting
  • Chronic Myelogenous Leukemia
  • ABL001 40mg BID
  • +2 more
  • Caba, Buenos Aires, Argentina
  • +53 more
Jan 27, 2023

Leukemia, Chronic Myelogenous Trial in China (asciminib, best available treatment)

Recruiting
  • Leukemia, Chronic Myelogenous
  • Chongqing City, Chongqing, China
  • +23 more
Jan 18, 2023

Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Amman, Jordan
  • +4 more
Jan 17, 2022

Vascular Occlusive Events Associated With ICLUSIG®

Terminated
  • Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
    • Hackensack, New Jersey
    • +1 more
    Oct 30, 2020

    Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

    Recruiting
    • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

    Not yet recruiting
    • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
    • (no location specified)
    Jul 11, 2022

    Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

    Recruiting
    • Acute Myelogenous Leukemia (AML) Due to Therapy
    • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
    • Orange, California
    • +2 more
    Nov 30, 2022

    Chronic Leukemia Trial in France (Additional biological samples)

    Active, not recruiting
    • Chronic Leukemia
    • Additional biological samples
    • Besançon, France
    • +3 more
    May 31, 2022

    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Acute Lymphoblastic Leukemia
    • Bordeaux, Aquitaine, France
    • +11 more
    Dec 6, 2020

    Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

    Recruiting
    • Philadelphia Chromosome
    • +4 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jun 23, 2022

    CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

    Not yet recruiting
    • CML (Chronic Myelogenous Leukemia
    • (no location specified)
    Jul 27, 2022

    CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE, CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISIS Trial in France

    Recruiting
    • CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE
    • CHRONIC MYELOGENOUS LEUKAEMIA IN MYELOID BLAST CRISIS
    • Amiens, France
    • +28 more
    Aug 6, 2020

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Nilotinib
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Mar 15, 2022

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Recombinant Interleukin-7
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 26, 2023

    Chronic Myeloid Leukemia Trial (Asciminib)

    Available
    • Chronic Myeloid Leukemia
    • (no location specified)
    Jan 17, 2023

    Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Beijing, China
      Peking University People's Hospital(北京大学人民医院)
    Jan 3, 2022

    B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 25, 2022

    Chronic Myeloid Leukemia Trial in France (Venetoclax)

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Amiens, France
    • +14 more
    Mar 3, 2023

    Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

    Completed
    • Hematopoietic/Lymphoid Cancer
    • +135 more
    • beclomethasone dipropionate
    • +4 more
    • Hackensack, New Jersey
    • +1 more
    Feb 1, 2021

    Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • +3 more
    • Augusta, Georgia
    • +1 more
    Jul 14, 2022

    Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone

    Withdrawn
    • Drug/Agent Toxicity by Tissue/Organ
    • +3 more
    • amifostine trihydrate
    • +2 more
    • Chicago, Illinois
    • +3 more
    Jan 31, 2023

    Chronic Myeloid Leukemia Trial in France (biological samples)

    Completed
    • Chronic Myeloid Leukemia
    • biological samples
    • Belfort, France
    • +3 more
    May 31, 2022

    Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

    Recruiting
    • Olverembatinib
    • +2 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Jul 26, 2022